Evidence map›Paper›PMID 30152054›Full record

ArticleProtein science : a publication of the Protein Society2018

Cytosolic expression, solution structures, and molecular dynamics simulation of genetically encodable disulfide-rich de novo designed peptides.

Garry W Buchko, Surya V S R K Pulavarti, Victor Ovchinnikov, Elizabeth A Shaw, Stephen A Rettie, Peter J Myler, Martin Karplus, Thomas Szyperski, David Baker, Christopher D Bahl

Abstract read
In one paragraph

Article in Protein science : a publication of the Protein Society, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Directed evolution identifies high-affinity cystine-knot peptide agonists and antagonists of Wnt/β-catenin signaling.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  3. De novo designed protein inhibitors of amyloid aggregation and seeding.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  4. Article
  5. Review
  6. Antifungal symbiotic peptide NCR044 exhibits unique structure and multifaceted mechanisms of action that confer plant protection.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  7. Structural diversity in the Mycobacteria DUF3349 superfamily.Protein science : a publication of the Protein Society · 2020
    Article
  8. Article
  9. In Silico Insights towards the Identification of NLRP3 Druggable Hot Spots.International journal of molecular sciences · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Garry W BuchkoSeattle Structural Genomics Center for Infectious Diseases, Seattle, Washington.
Surya V S R K PulavartiDepartment of Chemistry, State University of New York at Buffalo, Buffalo, New York, 14260.ORCID 0000-0003-0888-9302
Victor OvchinnikovDepartment of Chemistry and Chemical Biology, Harvard University, Cambridge, Massachusetts.
Elizabeth A ShawDepartment of Chemistry, State University of New York at Buffalo, Buffalo, New York, 14260.
Stephen A RettieInstitute for Protein Design, University of Washington, Seattle, Washington, 98195.
Peter J MylerSeattle Structural Genomics Center for Infectious Diseases, Seattle, Washington.
Martin KarplusDepartment of Chemistry and Chemical Biology, Harvard University, Cambridge, Massachusetts.
Thomas SzyperskiDepartment of Chemistry, State University of New York at Buffalo, Buffalo, New York, 14260.
David BakerInstitute for Protein Design, University of Washington, Seattle, Washington, 98195.
Christopher D BahlInstitute for Protein Design, University of Washington, Seattle, Washington, 98195.ORCID 0000-0002-3652-3693

Funding

Modeling atomic structure of the EmrE multidrug pump to design inhibitor peptidesR03AI111416 · NIAID · HARVARD UNIVERSITY · PI KARPLUS, MARTIN · 2014 to 2015
$169k
NIAID NIH HHS HHSN272201200025CNIAID NIH HHS HHSN272201700059CNIAID NIH HHS R03 AI111416
6 · The paper itself

Abstract

Disulfide-rich peptides represent an important protein family with broad pharmacological potential. Recent advances in computational methods have made it possible to design new peptides which adopt a stable conformation de novo. Here, we describe a system to produce disulfide-rich de novo peptides using Escherichia coli as the expression host. The advantage of this system is that it enables production of uniformly

Indexed as

Molecular Dynamics SimulationCytosolDisulfidesNuclear Magnetic Resonance, BiomolecularPeptidesSolutionsDisulfidesPeptidesSolutionscomputational protein designde novo proteindisulfide-rich peptidemolecular dynamics simulationnuclear magnetic resonanceprotein purificationrosetta

Identifiers

PMID30152054
PMCPMC6194292

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.